In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sue Darcey

Senior Reporter

Washington, D.C.
Sue Darcey is a senior reporter covering the medical device and diagnostics industry. Her current fields of expertise and interest include monitoring medical device post market performance and safety, development of new genomic and laboratory developed tests, the influence of industry lobbying and campaign contributions over Senators’ and Representatives’ voting practices and lawmaking on devices, and FDA approvals of diagnostics for emerging diseases, including tests for Ebola and Zika viruses. A Washington, D.C.-based trade journalist with over 30 years’ experience covering Capitol Hill and regulatory agencies including FDA, CMS and the Environmental Protection Agency, Sue is constantly on the look-out for any problems or safety issues connected to device use, ways that firms resolve those issues, and any new regulations that arise from the challenges. 
Advertisement
Set Alert for Articles By Sue Darcey

Latest From Sue Darcey

Executive Order Gives HHS Power To Disclose True Device, Procedure Costs To Patients

Despite industry opposition, President Trump signed a cost transparency executive order giving HHS the regulatory power to reveal to the public, health-care facilities’ costs of devices and procedures.

Reimbursement Private Payers

US House Agrees To Retain 8% Boost In Funding For FDA's Device Center Next Year

The US House completed work on the FDA portion of an appropriations “minibus” bill for 2020 on 20 June, agreeing to retain an approximate 8% increase for the agency’s device center.

Legislation FDA

Device Week, 14 June 2019: Genomic Spy Games?

In this week's Medtech Insight podcast, executive editor Shawn M. Schmitt and senior reporter Sue Darcey discuss recent reporting on efforts by US senators to control and stop Chinese researchers in the US from using their research jobs at the National Institutes of Health, and at American medical colleges and universities, to steal genomic data and share it with the Chinese government.

Device Week China

US Legislators To Rein In Surprise Laboratory, Imaging, Other Health-Care Bills

The US House Energy and Commerce Committee’s Health Subcommittee held a hearing on 12 June on proposed legislation to end “surprise medical billing,” spurred in part by out-of-network laboratory and advanced imaging bills, while Senate HELP Committee leaders continued to promote their own draft Lower Health Care Cost Act, addressing similar issues.

Legislation Reimbursement

US Senators Ask HHS IG To Investigate CMS Genetic Test Payments To Chinese Firms

Two Republican senators this week asked the HHS Office of Inspector General (OIG) to look into suspected CMS payments and trading of US citizens’ genomic information with US-partnered Chinese laboratory companies.

Policy Research and Development Strategies

Sen. Cornyn Plans Bill To Secure US Genomic Research From Foreign 'Interference, Espionage And Exfiltration'

Threats from Chinese and other foreign researchers stealing US medical research and genomic intellectual property for their home countries’ gain continue, and in response, one Texas senator plans to introduce a Secure Our Research Act to protect federally funded research from foreign theft.

Legislation Research and Development Strategies
See All
Advertisement
UsernamePublicRestriction

Register